Oxford Instruments PLC
07 April 2008
April 7 2008
Oxford Instruments plc
Disposal of holding in Oxford Diffraction Limited.
Oxford Instruments plc ("Oxford Instruments"), the high technology tools and
systems company, today announces the disposal of its 23% holding in Oxford
Diffraction Limited ("Oxford Diffraction") to Varian, Inc. for a cash
consideration of £3.5m. An additional cash amount of up to £1.1m may be received
over the next three years conditional on the performance of Oxford Diffraction.
The cash will be used to reduce Oxford Instruments' debt.
Oxford Diffraction, based in Abingdon, near Oxford in the UK, was spun out of
Oxford Instruments plc in March 2001 in order to develop, manufacture and supply
analytical instrumentation for X-ray crystallography. As this technique was not
core to Oxford Instruments it was decided to develop it as an independent
company using outside capital and resources.
Oxford Instruments has treated its holding in Oxford Diffraction Limited as an
investment, the carrying value of which was £0.3m at 30 September 2007. This
disposal will result in a non-recurring profit, before costs, of approximately
£3.2m on the initial consideration of £3.5m.
Enquiries:
Oxford Instruments plc Tel: 01865 393 200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
Hogarth Partnership Tel: 020 7357 9477
Rachel Hirst
Andrew Jaques
Ian Payne
Notes to Editors
Oxford Instruments designs, supplies and supports high-technology tools,
processes and solutions with a focus on physical science, bioscience,
environmental and industrial research and applications. It provides solutions
needed to advance fundamental nanoscience research and its transfer into
commercial nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 40 years, and its
strategy is to effect the successful commercialisation of these ideas by
bringing them to market in a timely and customer-focused fashion.
The first technology business to be spun out from Oxford University over forty
years ago, Oxford Instruments is now a global company with over 1,300 staff
worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to
be the leading provider of new generation tools and systems for the Physical
Science and Bioscience sectors.
This involves the combination of core technologies in areas such as low
temperature and high magnetic field environments, Nuclear Magnetic Resonance,
X-ray electron and optical based metrology, and advanced growth, deposition and
etching. Our products, expertise, and ideas address global issues such as
energy, environment, terrorism and health and are part of the next generation of
telecommunications, energy products, environmental measures, security devices,
drug discovery and medical advances.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.